This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.
OTC
HealthdirectFree Australian health advice you can count on.
60 mg/1, Tablet, film coated
INN: RALOXIFENE HYDROCHLORIDE
Data updated: 2026-04-25
Available in:
🇨🇿🇩🇪🇬🇧🇵🇹🇸🇰
Form
TABLET, FILM COATED
Dosage
60 mg/1
Route
ORAL
Storage
—
About This Product
User Reviews
Reviews reflect personal experiences and are not medical advice. Always consult your doctor.
Manufacturer
Exelan Pharmaceuticals, Inc.
ATC Code
G03XC01
Source
OPENFDA_NDC
(
ARTG
)
The prevention and treatment of osteoporosis in post-menopausal women.,The reduction in the risk of invasive breast cancer in postmenopausal women with osteoporosis.,The reduction in the risk of invasive breast cancer in postmenopausal women at high risk of invasive breast cancer.,High risk of breast cancer is defined as at least one breast biopsy showing lobular carcinoma in situ (LCIS) or atypical hyperplasia, one or more first-degree relatives with breast cancer, or a 5-year predicted risk of breast cancer greater than 1.66 percent (based on the modified Gail model). Among the factors included in the modified Gail model are the following: current age, number of first-degree relatives with breast cancer, number of breast biopsies, age at menarche, nulliparity or age of first live birth. Currently, no single clinical finding or test result can quantify risk of breast cancer with certainty.